CareWorks is Acquired by Advanced to Boost Delivery of Health and Social Care

London, 21 November 2019. ACXIT’s partner FirstCapital advised CareWorks, a provider of cloud-based case management software for health and social care organisations, based in Dublin, on its recent acquisition by Advanced, the third largest provider of business software and services in the UK. This deal will extend Advanced’s capabilities to deliver integrated health and care solutions and ensure the support of the NHS Long Term Plan goals by both companies.

Weiter lesen

ACXIT advises on sale of Loibl material handling subsidiary

Frankfurt, 25 June 2019. Babcock & Wilcox Enterprises, Inc. issued the below statement regarding the transaction:

Babcock & Wilcox Enterprises, Inc. („B&W“) (NYSE: BW) announced today that it has sold its Straubing, Bavaria, Germany-based material handling subsidiary, Babcock & Wilcox Loibl GmbH (Loibl), to a subsidiary of Deutsche Invest Mittelstand GmbH.

Weiter lesen

11th Annual International M&A Awards: Verkauf der Medpex Versandaktivitäten an die Schweizer Zur Rose Gruppe als Healthcare / Life Sciences Transaktion des Jahres ausgezeichnet

Frankfurt, 06. Juni 2019. Am Mittwoch, 5. Juni 2019 wurden im Rahmen des Global Corporate Growth Summit 2019 in New York die Gewinner der 11. Internationalen M&A Awards präsentiert. Der von ACXIT Capital Partners beratene Verkauf der Versandaktivitäten von medpex an die Zur Rose Gruppe wurde zum Gewinner in der Kategorie Healthcare / Life Sciences Transaktion des Jahres gekürt.

Weiter lesen

ACXIT CAPITAL PARTNERS ADVISED EUROPEAN HEALTHCARE PRIVATE EQUITY SPECIALIST ARCHIMED ON THE ACQUISITION OF ITALIAN IN VITRO DIAGNOSTICS COMPANY DIESSE DIAGNOSTICA SPA

Frankfurt, 29 May 2019. On May 22, 2019, ArchiMed announced the purchase of Diesse Diagnostica Senese SpA (‘Diesse’) by Duomodiag Sarl, a holding company backed by ArchiMed through its MED II fund, with bank finance provided by leading Italian banks MPS Capital Services and BPER. The transaction was completed on May 13, 2019. Diesse was acquired from its founders and from Orphée SA, the Swiss subsidiary of Warsaw listed diagnostics group PZ Cormay SA.

Weiter lesen